BC
Blackcrane Capital Portfolio holdings
AUM
$16.3M
This Quarter Return
+50.63%
1 Year Return
-19.53%
3 Year Return
+33.91%
5 Year Return
–
10 Year Return
–
AUM
$88.4M
AUM Growth
+$88.4M
(-19%)
Cap. Flow
-$200M
Cap. Flow
% of AUM
-225.83%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
–
Reduced
8
Closed
1
Top Buys
| 1 |
IMDX
Insight Molecular Diagnostics Inc. Common Stock
IMDX
|
$5.7M |
Top Sells
| 1 |
Avita Medical
RCEL
|
$130M |
| 2 |
WIX.com
WIX
|
$27.5M |
| 3 |
Microsoft
MSFT
|
$13.8M |
| 4 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
$11.3M |
| 5 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$10.6M |
Sector Composition
| 1 | Healthcare | 69.34% |
| 2 | Technology | 30.66% |
| 3 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Avita Medical
RCEL
$117M
| $28.1M | 31.84% |
921,663
-4,244,675
| -82% | -$130M |
|
|
2
WIX.com
WIX
$7.85B
| $16M | 18.08% |
62,379
-107,295
| -63% | -$27.5M |
|
|
AXNX
3
DELISTED
Axonics, Inc. Common Stock
AXNX
| $15M | 17.01% |
428,359
-321,980
| -43% | -$11.3M |
|
|
BHVN
4
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $8.98M | 10.16% |
122,865
-145,003
| -54% | -$10.6M |
|
5
Nice
NICE
$8.73B
| $8.26M | 9.35% |
43,657
-23,194
| -35% | -$4.39M |
|
|
IMDX
6
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$72.4M
| $5.7M | 6.44% |
+2,982,557
| New | +$5.7M |
|
|
PROF
7
Profound Medical
PROF
$134M
| $2.97M | 3.36% |
175,301
-47,246
| -21% | -$800K |
|
|
8
Microsoft
MSFT
$3.77T
| $2.86M | 3.23% |
14,039
-67,922
| -83% | -$13.8M |
|
9
Takeda Pharmaceutical
TAK
$47.3B
| $461K | 0.52% |
25,723
-109,734
| -81% | -$1.97M |
|
10
Visa
V
$683B
| – | – |
-33,024
| Closed | -$5.32M |
|